首页|李可治疗脓毒症临床经验探析

李可治疗脓毒症临床经验探析

扫码查看
脓毒症是因感染所致机体炎症反应失调而引起的致命性器官功能障碍,可伴随多种并发症,致死率高.李可是中医急危重症的大家,曾用经方及自创方治疗大量危重症患者,被称为一代霹雳大医.李可治疗急危重症具有个人特色,若认为人体本气自病,当扶正抗邪;遇热毒内炽,霹雳攻承,扫荡血毒;病证冲突,舍病从证,弃标治本;采用经方剂量,药简力专,直捣病巢;针药结合,双法并施,内外同调;天人合一,时间辨证,以遏病势;随煎随服,争取时间,力挽危亡等.本文通过分析李可的学术思想及临床经验探究脓毒症的中医治法.
Exploration and analysis on Li Ke's clinical experience in the treatment of sepsis
Sepsis is fatal organ dysfunction caused by imbalance of inflammatory response in the body due to infection,which can be accompanied by various complications and has high mortality rate.Li Ke is a great master of acute and critical illnesses in Chinese medicine.He has treated a large number of patients with critical illnesses with scriptural prescriptions and self-created formulas,and is known as a generation of thunderbolt doctor.Li Ke has personal characteristics for treating acute severe diseases such as sepsis.Li Ke has his own characteristics in treating acute and critical diseases.If it is believed that the body's natural qi is self-sick,it is necessary to support the body's vital energy and resist the evil;in the event of heat and poison within the blaze,thunderbolt attack bearing,sweeping the blood poison;disease and syndrome conflict,giving up disease and following syndrome,abandoning the standard and treating the root cause;the use of prescription dosage,the drug is simple and force specialization,directly hit the nest of the disease;the combination of needles and drugs,dual method of implementation,internal and external co-ordination;the unity of the heavenly and human beings,the time to dialectic,in order to curb the momentum of the disease;along with the decoction with the service to fight for time to salvage the death of the crisis,and so on.This article explores traditional Chinese medicine treatment methods for sepsis by analyzing Li Ke's academic ideas and clinical experience.

SepsisTraditional Chinese medicineLi KeTraditional Chinese medicine treatment methods

张蔚佳、李淑芳

展开 >

上海中医药大学附属曙光医院重症医学科,上海 200021

脓毒症 中医药 李可 中医治法

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(23)